SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-149215
Filing Date
2021-12-13
Accepted
2021-12-13 18:53:52
Documents
1
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135158-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135158-5_4seq1.xml 4 3925
  Complete submission text file 0001104659-21-149215.txt   5493
Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY SUITE 100 NEWARK DE 19711
Business Address
MCKEY JOHN D JR (Reporting) CIK: 0001120452 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 211489263

Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations